Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
基本信息
- 批准号:10553188
- 负责人:
- 金额:$ 41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-21 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdaptive Immune SystemAddressAdultB-LymphocytesBacterial InfectionsBiochemicalBiochemistryBiologicalBiological ProcessCell Differentiation processCell LineageCell MaturationCellsChIP-seqChronicCommunicable DiseasesComplexCytoprotectionDangerousnessDataDevelopmentDevelopmental GeneEnterobacteria phage P1 Cre recombinaseEnvironmentEvaluationEventExposure toFamilyFunctional disorderGatekeepingGene ExpressionGene Expression RegulationGene SilencingGenesGenetic TranscriptionGleanGoalsGram-Negative Bacterial InfectionsHematopoieticHomeoboxHomeodomain ProteinsHumanHuman BiologyIL8 geneImmuneImmune systemImmunologicsImmunologyIn VitroInfectionInflammationInflammatoryInflammatory ResponseInnate Immune SystemKnockout MiceLinkLoxP-flanked alleleLymphoidMammalsMediatingModelingModernizationMolecularMorbidity - disease rateMusNF-kappa BNFKB Signaling PathwayOrganOrganismOrganogenesisOsteoclastsPathogenicityPathway interactionsPatternPhysiologicalPlayPluripotent Stem CellsProteinsRegulationRegulatory PathwayResolutionRoleSignal PathwaySignal TransductionSiteStressSystemTNF geneTestingTherapeutic InterventionTissuesTransgenic MiceWorkcell typechemokinechronic inflammatory diseasecombatcytokinedesigngene functiongene networkgenetic corepressorgenome-widehuman diseaseimmune activationimmune system functionin vivoinhibitorinnovationinsightmicrobialmodel organismmouse modelnew therapeutic targetnovelnovel therapeuticspathogenpathogenic bacteriapathogenic microbepersistent bacterial infectionprogramspromoterprotein activationprotein expressionprotein functionreconstitutionrecruitresponsetissue injurytranscription factortranscriptome sequencing
项目摘要
Project Summary
The present study focuses on our discovery that developmentally silenced SIX-family transcription
factors are reactivated by TNF-family cytokines and potently suppress gene expression programs
induced by non-canonical NF-kB. By first characterizing the human cytokines and pathogen
associated molecular patterns (PAMPs) that induce Six1 and Six2 protein expression and by then
investigating the molecular components required for their reactivation (Aim 1), these studies will
reveal a new pathway for non-canonical NF-kB regulation in the mammalian immune system. Second,
we will determine how Six-proteins inhibit inflammatory gene expression programs through promoter
proximal mechanisms (Aim 2). Physiological significance of inflammatory resolution by Six-proteins
while be investigated in mammalian model organisms using three complementary mouse models of
Six1 protein function (Aim 3). Insights gleaned from these studies will explain how non-canonical NF-
kB is regulated at gene promoters and will also reveal co-repressor complexes that play important
roles in the inflammatory response to microbial pathogens. Developing new drugs that interfere with
the ability of SIX proteins to regulate non-canonical NF-kB during microbial infection would be an
innovative approach to combat human disease associated with NF-kB signaling dysfunction including
chronic inflammation. Therefore, by revealing molecular details of SIX-protein function in the
mammalian immune system, from biochemistry to mouse models of infection, we will uncover sites of
potential weakness that may be exploited for therapeutic intervention. Importantly, these studies will
also provide new insights into the pathogenic mechanisms of an important infectious disease-causing
agent and also into the biology of the human inflammatory response.
项目概要
本研究的重点是我们发现发育上沉默了六个家族的转录
因子被 TNF 家族细胞因子重新激活并有效抑制基因表达程序
由非典型 NF-kB 诱导。首先表征人类细胞因子和病原体
诱导 Six1 和 Six2 蛋白表达的相关分子模式 (PAMP),然后
研究其重新激活所需的分子成分(目标 1),这些研究将
揭示了哺乳动物免疫系统中非典型 NF-kB 调节的新途径。第二,
我们将确定六种蛋白如何通过启动子抑制炎症基因表达程序
近端机制(目标 2)。六种蛋白质消退炎症的生理意义
同时使用三种互补的小鼠模型在哺乳动物模型生物体中进行研究
Six1 蛋白质功能(目标 3)。从这些研究中收集到的见解将解释非典型的 NF-
kB 在基因启动子处受到调节,并且还将揭示发挥重要作用的共阻遏物复合物
在对微生物病原体的炎症反应中发挥作用。开发干扰的新药物
六种蛋白质在微生物感染期间调节非经典 NF-kB 的能力将是
对抗与 NF-kB 信号传导功能障碍相关的人类疾病的创新方法,包括
慢性炎症。因此,通过揭示六种蛋白质功能的分子细节
哺乳动物的免疫系统,从生物化学到小鼠感染模型,我们将揭开免疫系统的位点
可用于治疗干预的潜在弱点。重要的是,这些研究将
还为重要传染病的致病机制提供了新的见解
剂,也涉及人类炎症反应的生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neal Mathew Alto其他文献
Neal Mathew Alto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neal Mathew Alto', 18)}}的其他基金
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10328259 - 财政年份:2020
- 资助金额:
$ 41万 - 项目类别:
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10112827 - 财政年份:2020
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8235694 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8788709 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8415960 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8603244 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Type III effector regulation of host GTPase signaling
宿主 GTPase 信号转导的 III 型效应器调节
- 批准号:
8503581 - 财政年份:2009
- 资助金额:
$ 41万 - 项目类别:
相似国自然基金
转录因子LeuO激活适应性免疫系统CRISPR/Cas防御大肠杆菌自然转化的机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
适应性免疫系统的发育和应答
- 批准号:
- 批准年份:2020
- 资助金额:400 万元
- 项目类别:国家杰出青年科学基金
肠道共生细菌与七鳃鳗可变淋巴细胞受体VLRA、VLRC交联对话( Cross-talk)机制研究
- 批准号:31500106
- 批准年份:2015
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
不同年龄牦牛免疫系统发育特征及其对高原环境的适应机制
- 批准号:31572478
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
The developmental pathway of fetal-derived B cells
胎儿来源的 B 细胞的发育途径
- 批准号:
10735381 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别: